Public Company

More support for Sun Pharma in Taro takeover battle

Glass, Lewis & Co, LLC, an independent proxy advisory firm has recommended the shareholders of Taro Pharmaceutical Industries to vote against the proposals made by Taro’s board of directors in the upcoming annual general meeting of Taro’s shareholders scheduled for December 31. Earlier, another investment advisory firm Proxy Governance, had recommended the shareholders of Taro to withheld their votes in the ensuing annual general meeting (AGM) of the company on the eve of new year.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

News of the day
Disinvestment roadmap to be ready by March
Encouraged by the outcome of earlier initiatives, the Centre is preparing a roadmap to take the disinvestment process forward over the next two years.
Popular Articles
payday loan lenders

M&M automotive sales grow 18.72% in June
Auto major Mahindra & Mahindra today reported 18.72 per cent growth in its total automotive sales in June at 22,999 units compared with 19,371 units in the corresponding month last year.

Dr Reddy's, AstraZeneca may settle patent case out of court
Dr Reddy"s Labs long-standing patent dispute with Europe"s AstraZeneca over a drug to treat heartburn may be resolved out of court following a similar settlement between the European drug maker and Israel"s Teva, feel market watchers.